COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 45.000 shares in Solon Eiendom ASA at a price of NOK 21.8681. Following [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 45,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA Board Member Edvin Austbø (through his wholly owned company Alden AS) has today bought 45,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per share. [...]
Solon Eiendom ASA : Primary insider notification
02/02/2018
(Oslo, Norway, February 01, 2018) Solon Eiendom ASA CEO Andreas Martinussen (through his wholly owned company John Galt AS) has today bought 50,000 shares in Solon Eiendom ASA at a price of NOK 21.8681 per share. [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
02/02/2018
REGULATED INFORMATION GHENT, Belgium, 2 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM
02/02/2018
Geneva, Switzerland, 2 February 2018 - Addex Therapeutics (SIX: ADXN) announced today that the independent life science research company Van Leeuwenhoeck has issued an equity research note highlighting the value of the [...]
Targovax ASA: Exercise price of options
02/02/2018
With reference to the Stock exchange notification issued 1 February 2018 regarding options to employees: The exercise price of the granted options is NOK 17.17. The exercise price is equal to the volume weighted average [...]
INSYS Therapeutics Addresses New York Attorney General’s Complaint
02/02/2018
PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the [...]
Kane Biotech Provides Additional Information Regarding Engagement of Investor Relations Counsel
02/02/2018
WINNIPEG, Manitoba, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce additional information regarding its engagement of Edison [...]
MedMira Announces AGM Results and Stock Option Grant
02/02/2018
HALIFAX, Nova Scotia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV:MIR) held its 2018 Annual General Meeting of Shareholders on January 31, 2018 in Halifax, Nova Scotia. Incumbent Directors Mr. Hermes [...]
Revocation of CTO and Reinstatement to Trade
02/02/2018
BROSSARD, Québec, Feb. 01, 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (TSX Venture Exchange:ZMD) (“ZoomMed”) is pleased to announce that the TSX Venture Exchange will be issuing a bulletin to reinstate trading in ZoomMed’s [...]
Levée de l’interdiction d’opérations et reprise de la négociation
02/02/2018
BROSSARD, Québec, 01 févr. 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (Bourse de croissance TSX:ZMD) (“ZoomMed”) est heureuse d’annoncer que la Bourse de croissance TSX émettra un bulletin visant la reprise de la négociation [...]
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression in the SPRINT-MS Phase 2b Trial in Progressive MS: Potential Best-in-Disease Drug
02/02/2018
LA JOLLA, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Marrone Bio Innovations, Inc. Announces Stockholder Approval of Private Placement and Debt Refinance Transactions
01/02/2018
Appoints Two New Board Members; Bob Woods as Chairman and Yogesh Mago Transactions Expected to Close in Early February DAVIS, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (“MBI” or the “ [...]
Progenics Pharmaceuticals Announces Presentation of AZEDRA® (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society (ENDO) Annual Meeting
01/02/2018
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, today [...]
Quest Diagnostics Completes Acquisition of MedXM
01/02/2018
Secaucus, NJ, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of [...]
Integra LifeSciences to Host Fourth Quarter 2017 Earnings Results Conference Call on February 27, 2018
01/02/2018
PLAINSBORO, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, will release fourth quarter and full year 2017 financial [...]
Retrophin to Present at the Leerink Partners 7th Annual Global Healthcare Conference
01/02/2018
SAN DIEGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that Stephen Aselage, chief executive officer, will present at the Leerink Partners 7th Annual Global Healthcare Conference in [...]
Syneos Health Schedules Fourth Quarter and Year End 2017 Earnings Call for Wednesday, February 28, 2018
01/02/2018
RALEIGH, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year end 2017 financial results [...]

Pages